To investigate the functional roles of SELL, RAMP2, and CD79B in GC progression, we performed siRNA-mediated knockdown of these genes in GC cell lines and assessed their impacts on tumor-associated pathways via qPCR. This evidence concerns the gene CD79B and neoplasm.